Key partnership increases access to organoid models
20 Aug 2024
Patient-derived organoids address the urgent need for more predictive in vitro models for biopharmaceutical applications. However, challenges around standardization and scale up remain. Dr. Francisco Morales-Rodriguez shares insight into the partnership between HUB Organoids and Molecular Devices, which aims to increase the access of organoids for both academia and industry. Here, he highlights the integral role of the ImageXpress® Micro Confocal High-Content Imaging System and its suite of software solutions in providing high image quality, high throughput, and flexibility that HUB Organoids requires.
This video was filmed at SLAS Europe 2024.
About the company
Molecular Devices®
Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics. Molecular Devices is committed to the continual development of innovative solutions for life science applications. The company is headquartered in Silicon Valley, California, with offices around the globe. For more information, please visit www.moleculardevices.com.
General Inquiry - USA & Canada: +1 800-635-5577 General Inquiry - Europe: 00800 665 32860 Sales +1 877-589-2214 Support +1 800 635 5577
Related products
Request Quote for All Products
ImageXpress® Micro Confocal High-Content Imaging System
Molecular Devices®Explore the new dimension with the confocal system for your complex biology.
ImageXpress HCS.ai High-Content Screening System
Molecular Devices®A fast, intuitive and versatile system delivering deeper insights for every lab
